All In Biotech

Drug Trial Radar · NCT02249104

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris

Last checked: Nov 20, 2026Latest source record: Aug 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

28

Actual

Start

Aug 2014

Primary completion

Feb 2015

Study completion Feb 2015

Sponsor

Lead sponsor
Galderma R&DIndustry
Sponsor type
Industry
First posted
Sep 25, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControl™ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControl™ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.

Conditions

  • Acne Vulgaris

Interventions

  • Adapalene/benzoyl peroxide gel, 0.1%/2.5%Drug

    Topical AV therapy

  • Cetaphil Acne RegimenOther

    Cleanse, Moisturize, and Protect

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline in Total Lesion CountTime frame: Baseline and 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Pflugerville Dermatology Clinical Research

    Pflugerville, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.